NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

NCT05205343

RecruitingN/A

Sponsor: M.D. Anderson Cancer Center

Conditions: Gastrostomy, Gastric, GastroEsophageal Cancer

Interventions: Standard of Care, Control Group

Countries: United States, Japan, South Korea

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion:

1. Able to speak and read English, Spanish, Japanese or Korean
2. Participants with a biopsy-confirmed diagnosis of non-metastatic gastric or GEJ adenocarcinoma, who are scheduled to undergo MIPG or MITG for curative-intention
3. Age ≥ 18

Exclusion:

1. Participants with known malabsorption syndromes or a lack of physical integrity of the upper gastrointestinal tract
2. Participants with known narcotic dependence, with average daily dose \> 5 mg oral morphine equivalent
3. Participants deemed unable to comply with study and/or follow-up procedures, at investigators' discretion
4. Participants who are pregnant (since are excluded from receiving standard-of-care MIPG or MITG)

Locations (4)

Rochester, Minnesota, United States
Houston, Texas, United States
Tokyo, Japan
Soeul, South Korea